| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.56B | 11.03B | 10.22B | 9.17B | 8.49B | 7.89B |
| Gross Profit | 7.98B | 7.89B | 7.82B | 7.37B | 6.79B | 6.22B |
| EBITDA | 5.90B | 5.36B | 5.20B | 4.94B | 4.24B | 3.81B |
| Net Income | 3.58B | 3.59B | 3.49B | 3.26B | 2.86B | 2.46B |
Balance Sheet | ||||||
| Total Assets | 30.73B | 29.40B | 33.01B | 30.11B | 28.00B | 25.26B |
| Cash, Cash Equivalents and Short-Term Investments | 12.20B | 12.71B | 16.62B | 15.84B | 17.53B | 18.50B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.98B | 6.97B | 6.62B | 5.98B | 6.00B | 5.54B |
| Stockholders Equity | 22.73B | 20.38B | 24.36B | 22.34B | 20.51B | 18.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.95B | 3.97B | 2.92B | 2.73B | 2.56B |
| Operating Cash Flow | 0.00 | 4.01B | 4.10B | 3.13B | 3.24B | 2.66B |
| Investing Cash Flow | 0.00 | 1.30B | 311.33M | -4.28B | -4.19B | -1.82B |
| Financing Cash Flow | 0.00 | -7.81B | -1.44B | -1.33B | -713.10M | -87.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥415.10B | 12.89 | 14.42% | 4.80% | 3.10% | 2.91% | |
75 Outperform | ¥24.07B | 13.71 | ― | 2.50% | 16.18% | 28.23% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥78.52B | 20.71 | ― | 2.02% | 7.88% | 6.55% | |
65 Neutral | ¥38.60B | 20.77 | ― | ― | 9.59% | 25.89% | |
64 Neutral | ¥84.38B | 10.60 | ― | 2.44% | 20.96% | 28.21% | |
60 Neutral | ¥4.60B | 11.42 | ― | 2.04% | 14.62% | 225.91% |